Women obsessively testing their vaginas to optimize them

The rapid growth of the at-home vaginal microbiome testing industry is sparking a debate between women seeking to resolve chronic health issues and medical experts who warn that the unapproved tests may promote unnecessary anxiety and risky self-treatment.

The market for at-home vaginal microbiome testing is experiencing a significant surge, fueled by social media visibility and a growing community of women seeking alternatives to traditional healthcare. Startups like TinyHealth, Evvy, and Juno Bio allow users to quantify their internal bacterial ecosystems, often searching for high levels of Lactobacillus crispatus, a “good” bacterium associated with infection resistance. For many, like Farrah, a dancer who suffered for years with undiagnosed pain, these $150 kits offer a sense of clarity that clinical visits failed to provide. “I was just so glad to actually know what was wrong,” she says, after her results led her to a diagnosis of aerobic vaginitis and a subsequent recovery.

Despite the anecdotal success stories, the industry has birthed a culture of “optimization” that some observers find concerning. In online communities, women frequently compare their percentages of “protective” bacteria, leading to what some describe as a distinct strain of paranoia. Samantha, a user who sought help for recurring infections, noted that “I’ll read posts where women are freaking out if they have like 97 percent crispatus and then they’ll retest and they’ll have like 60 percent and be really disappointed and scared.” This competitive approach to health is exemplified by longevity researchers who test biannually to maintain perfect scores, even while asymptomatic, viewing the results as a metric of self-competition.

Medical experts and researchers urge caution, noting that none of these kits are FDA-approved and that the vaginal microbiome is naturally “a very dynamic system.” Jacques Ravel, a researcher at the University of Maryland, warns that because the ecosystem fluctuates based on diet, menstruation, and ethnicity, one-time snapshots can be misleading. He argues that introducing unnecessary antibiotics or probiotics based on these tests is “dangerous” and can lead to worsening irritation. “Knowing what happened at one point in your life won’t really tell you much about what’s going to happen even two weeks from now,” Ravel notes, highlighting the gap between commercial data and clinical validity.

READ THE FULL STORY IN WIRED